Opus MK5
Unit dose packaging for oral liquids.
For alcohol gel syrups, creams, herbal medicines or cleaning products.
“The oral liquid fractionation machine MK5 allowed us to be more suitable in the dispensing process of most meds in the liquid pharmaceutical form of oral/enteral use previously available in multi-dose vials.
With the acquisition of this automated solution, the pharmacy service had a significant increase in productivity in the Pharmacy Unit Dose, began to produce sachets with fractional volumes of liquid meds fully traceable, with DataMatrix code, with safety alerts in their packaging, with signs for controlled medicines and for those with reduced validity.
It decreased losses due to bottle sharing and minimized risks of adverse events due to the availability of these drugs in care units. Sachet packaging is economical, practical, easy to use and open.”
An amazing solution of compact size and highly functional
Opus MK5 is a mobile, compact and highly functional oral liquid fractionating machine. Starting from a coil, it fractionates a quantity of liquid, prints a package and seals it, completing the unit dose process.
It can be used for any liquid in the hospital, from syrups and creams to hygiene and cleaning products.
Opus MK5 packaging prevents waste and replaces higher cost packaging and bottles. The machine has sterilizable ducts and the sachets are printed with the information of the oral liquid.
Sterilizable machine duct. 2 units included.
Device to fully empty the liquid from the bottles. The funnel has control of the end of the product.
Occupies a small area in the Hospital Pharmacy
Uma área de 1,30 x 1,30 é suficiente para operação.
Specifications
Sachet packagings from 30 x 50 mm up to 50 x 250 mm.
Uses peristaltic pump.
Dosage accuracy from 3 % to 5 % for small volumes.
Productivity: 1,200 units per hour.
Input power: 220V AC.
System to facilitate the cleaning and sterilization of parts in contact with the product.
Patent: PI0105649-2NPI061.
Very functional packaging, opens very easily and avoids the use of cups.
It has a sensor wich stops the machine when the liquid is over.
Easy operation.
Savings and Return on Investment:
Case of a 250 bed hospital
Case of a 250 bed hospital
Entry of 1,000 bottles of syrup to the infirmaries per month.
Syrup vial unit average cost = U$ 12.50
Monthly cost = U$ 12,500.00
Waste: the product is discarded in the trash when the patient is discharged.
Product does not drain completely from bottle.
Estimated waste: 30%.
Potential savings: U$ 3,750/mo.
RoI = Return of Investment < 7 months.
Opus MK5 brochure, machine for fractionation and unit dose of liquids - syrups, creams, herbal medicines, alcohol gel, cleaning products and others (PDF).
Size: 6.09 MB
Register to download
Know other Opuspac solutions
Unidose Process Automation and Hospital Logistics for Meds and Mats is our specialty. You will find here many options and comprehensive solutions of equipments, materials, software, information, services and other solutions to best solve the specific case that involves your institution.
Unit Dose and Liquid Fractionating Machines
Unit Dose and Fractionation Machines or Opuspac medication distribution system, in addition to being easy to operate for the employee, greatly speeds up the process of dispensing medications per unit dose. They are innovative machines in the concern with patient safety, in the medication process, in the possibility of guidance on risks and alerts about medications for the care team, avoiding Adverse Events.
Why unitarize
Unitarization is the process of preparing meds in ready form to be administered to the patient.
This process is normally carried out at the Hospital Pharmacy, Medicines Storage Sector or Unit Dose Center for several hospitals, but always linked to the responsibility and control of the Hospital Pharmacy. Unitarization or fractionating of medicines is important to centralize the control of meds in the Hospital Pharmacy and to differentiate packaging. Also to place a hospital barcode.
The centralization of control allows a reduction of up to 57% of Adverse Events, according to two studies carried out in Germany and the USA.
